Amylin and Eli Lilly Split Partnership
Pharmaceutical giants Amylin Pharmaceuticals Inc. (NASDAQ:AMLN) and Eli Lilly (NYSE:LLY) said on Tuesday that they are putting an end to their drug development collaboration that was meant to work on new diabetes drug. The...